• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL CLARIA MRI CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL CLARIA MRI CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTMA2D4
Device Problems Pacing Problem (1439); Unable to Obtain Readings (1516); Output Problem (3005)
Patient Problem Weakness (2145)
Event Date 11/30/2019
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that during interrogation of the cardiac resynchronization therapy defibrillator (crt-d), markets were present, but no electrograms (egm) were visible and the device had no/low outputs.It was noted that it was impossible to perform any test on the device and obtain lead measurements.It was also noted that the patient had asthenia and a low junctional rhythm.The device was explanted and replaced.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Product event summary: the device was not returned for analysis.However, performance data collected from the device was received and analyzed.Analysis of the device memory indicated the lead impedance data was missing/invalid.Analysis of the device memory indicated missing/invalid ca pture/threshold.Analysis of the device memory had an observation relating to pacing.Analysis of the device memory indicated the egm (electrogram) was not available.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product event summary: the device was returned and analyzed.During the analysis of the returned device the failure on the hybrid disappeared.Device analysis confirmed the field allegations.Hybrid analysis revealed that there were at least four power on reset events, and the failure that was confirmed by the returned product analysis lab was cleared.The outputs were functional and lead measurements were nominal and product analysis lab tempe analysis did not confirm the failure, nor see any new power on resets.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLARIA MRI CRT-D SURESCAN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH   1131
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key9474829
MDR Text Key170934414
Report Number9614453-2019-04253
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/28/2017
Device Model NumberDTMA2D4
Device Catalogue NumberDTMA2D4
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/15/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/02/2019
Initial Date FDA Received12/16/2019
Supplement Dates Manufacturer Received12/17/2019
05/15/2020
Supplement Dates FDA Received12/18/2019
05/21/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/07/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
(B)(4) LEAD, (B)(4) LEAD, (B)(4) LEAD
Patient Outcome(s) Hospitalization; Required Intervention;
-
-